![DBCO-PEG9-DBCO se fragment [Multiple species] NSC 95397(10 μM](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M32690_1636112520.gif?v=1636112523)
Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
NSC 95397(10 μM
Morinidazole is a novel 5-nitroimidazole antimicrobial drug that undergoes extensive metabolism in humans via N+-glucuronidation and sulfation
86-dibenzyl-69-(3-carbamimidamidopropyl)-30-[(2-carbamoyl-1-{[1-({1-[(1-carbamoyl-2-phenylethyl)carbamoyl]-2-hydroxyethyl}carbamoyl)-2-phenylethyl]carbamoyl}ethyl)carbamoyl]-4
InChi: InChI=1S/C8H9ClN4
SiR-COOH could be used to conjugated inhibitors such as UNC2025 (Mer inhibitor)
DBCO-PEG9-DBCO se fragment [Multiple species] NSC 95397(10 μMDBCO PEG9 DBCO is a PEG based PROTAC linker that can be used in the synthesis of PROTACs. Product information CAS Number: 2353409 50 2 Molecular Weight: 1031. 20 Formula: C58H70N4O13 Chemical Name: N,N' bis(3 {2 azatricyclo[10. 4. 0. 0,]hexadeca 1(16),4,6,8,12,14 hexaen 10 yn 2 yl} 3 oxopropyl) 4,7,10,13,16,19,22,25,28 nonaoxahentriacontanediamide Smiles:
US$ 173.55
US$ 155.47
US$ 209.01
US$ 154.50
US$ 79.99
US$ 84.95
US$ 106.80
US$ 83.69
US$ 102.50
US$ 133.69
US$ 2885.00